TMEM158 oncogenic action was demonstrated in cell culture and mouse xenograft models derived from colon cancer (6), pancreatic cancer (10), ovarian cancer (12), glioblastoma (13), and triple-negative breast cancer (14). This evidence concerns the gene TMEM158 and ovarian carcinoma.